about
Vasopressin V1a and V1b receptors: from molecules to physiological systemsDysfunction of lipid sensor GPR120 leads to obesity in both mouse and humanDependence of soluble guanylyl cyclase activity on calcium signaling in pituitary cells.Signaling by purinergic receptors and channels in the pituitary gland.Inhibition of protein kinase CK2 prevents the progression of glomerulonephritisOxytocin stimulates expression of a noncoding RNA tumor marker in a human neuroblastoma cell line.alpha 1-Adrenergic receptor subtypes differentially control the cell cycle of transfected CHO cells through a cAMP-dependent mechanism involving p27Kip1.V1a vasopressin receptors maintain normal blood pressure by regulating circulating blood volume and baroreflex sensitivity.The alpha(1D)-adrenergic receptor directly regulates arterial blood pressure via vasoconstriction.Transgenic studies of alpha(1)-adrenergic receptor subtype function.The vasopressin V1b receptor critically regulates hypothalamic-pituitary-adrenal axis activity under both stress and resting conditions.Correlation between vasoconstrictor roles and mRNA expression of alpha1-adrenoceptor subtypes in blood vessels of genetically engineered mice.Insights into alpha1 adrenoceptor function in health and disease from transgenic animal studies.Functional role of spliced cytoplasmic tails in P2X2-receptor-mediated cellular signaling.Lipopolysaccharide-induced inflammation or unilateral ureteral obstruction yielded multiple types of glycosylated Lipocalin 2New topics in vasopressin receptors and approach to novel drugs: vasopressin and pain perception.Cranberry juice suppressed the diclofenac metabolism by human liver microsomes, but not in healthy human subjects.The roles of V1a vasopressin receptors in blood pressure homeostasis: a review of studies on V1a receptor knockout mice.Inhibition of heat shock protein 90 attenuates adenylate cyclase sensitization after chronic morphine treatment.Novel selective ligands for free fatty acid receptors GPR120 and GPR40.Flow cytometry-based binding assay for GPR40 (FFAR1; free fatty acid receptor 1).Free fatty acids induce cholecystokinin secretion through GPR120.Glucocorticoid-induced granzyme A expression can be used as a marker of glucocorticoid sensitivity for acute lymphoblastic leukemia therapy.Identification of ectodomain regions contributing to gating, deactivation, and resensitization of purinergic P2X receptors.Heteromultimerization modulates P2X receptor functions through participating extracellular and C-terminal subdomains.Molecular dissection of purinergic P2X receptor channels.Metastasis-associated protein, S100A4 mediates cardiac fibrosis potentially through the modulation of p53 in cardiac fibroblasts.Two novel transcripts for human endothelin B receptor produced by RNA editing/alternative splicing from a single gene.Role of the alpha1D-adrenergic receptor in the development of salt-induced hypertension.Vasopressin stimulates insulin release from islet cells through V1b receptors: a combined pharmacological/knockout approach.Two alpha1-adrenergic receptor subtypes regulating the vasopressor response have differential roles in blood pressure regulation.Cloning and characterization of the rat free fatty acid receptor GPR120: in vivo effect of the natural ligand on GLP-1 secretion and proliferation of pancreatic beta cells.Free fatty acids administered into the colon promote the secretion of glucagon-like peptide-1 and insulin.Carboxyl-terminal splicing enhances physical interactions between the cytoplasmic tails of purinergic P2X receptors.Chronic ritodrine treatment induces refractoriness of glucose-lowering β2 adrenoceptor signal in female mice.Complex formation between the vasopressin 1b receptor, β-arrestin-2, and the μ-opioid receptor underlies morphine tolerance.Expression of purinergic P2X2 receptor-channels and their role in calcium signaling in pituitary cells[Heterogeneity of G protein-coupled receptor generated by post-translational mechanisms and its clinical meanings]Production and characterization of a monoclonal antibody against GPR40 (FFAR1; free fatty acid receptor 1)Protective effect of α-lipoic acid against arsenic trioxide-induced acute cardiac toxicity in rats
P50
Q26823378-17709593-AD7B-462D-9768-3DEA35D8A30FQ28591078-38E49058-4331-482C-ACFE-FD93969B87A7Q31458764-20B9149B-BB2E-4052-AF9B-329FFC7AABA7Q33625696-7A486940-B66D-4A49-AA53-174D80BA458FQ33836248-B784E4FA-473F-49A4-BB4C-520AA6CF3116Q34098264-6814C78A-38BF-4055-8BC1-B5BA41D4F6A7Q34157087-1E489127-583A-4950-B25B-5FA668641B31Q34650901-369C233D-9810-4FAD-B377-BEA8A585CFB1Q34789836-030E4E9D-9E39-4E47-A09E-020A17C7BED7Q34821106-00CF8C4A-2A6E-459D-A22A-3BD5C83FA5A0Q35043245-57EBE8F9-02F6-44D9-8691-C27D82F6E331Q35049175-15237B4F-9854-4B6C-88E9-DD81F87FC1C7Q35096881-167DCCBD-7A1A-43C2-BA99-D84AD043AD1EQ36557793-D1BB4DEB-1C81-4270-8A8F-3171D4A45A24Q36655357-5DCEBC14-EBB6-466B-A51D-B8C4E25B8948Q37371531-BE59C03F-0302-4DF9-920F-BB94C865055FQ37399435-7DDAA81D-5038-46F1-9516-DF54E29BD266Q37950893-F7B501F1-31AD-4C07-9970-C3663B13C311Q39748212-B7E5F42E-66CF-46CE-8EA5-0BB4E86C779CQ39846718-7B648692-AD8B-4B64-8E89-86CD967F788AQ39928490-E7CB6AD2-4B8A-48A6-96F5-E64C640586EBQ40059721-B6C5F046-8FE8-46F3-8F14-9B4DBE64AFC2Q40169255-BFC3005C-5372-461D-90F9-360FA7CA3EC6Q40528321-D0EA686C-9396-4A92-A73C-4CB54290F5EAQ40699976-B91A713A-872F-4E85-A20D-113F932158FDQ42667565-F2CD6EA8-767B-4FF0-B21A-6604E824F3B2Q42826303-A3CF0C11-79A9-46DA-8114-522E451E2777Q44038767-AD0EAD63-B6FB-4464-A878-2901417CA5C3Q44053719-D286F624-72BA-41B7-BB39-EBCE2DEB5AEFQ44772906-31694D76-C34E-42A6-B350-C32DA449CC52Q45187308-3196C520-F6D6-4DAA-915B-A343A465EF77Q46718654-0C448102-9D66-47A5-B3E0-E4B5055C4D3DQ46852429-B7EBB6C8-D6B7-4EE0-9D9B-CCFDADC4A015Q46935071-B553307E-C5CC-4C81-BB56-2C7368EA884EQ51364201-C05608A2-9355-4922-9C17-09CC804BE2A6Q52715368-39BECAF3-E26E-4DA1-B6CD-224039160D82Q74191260-5E754A30-C588-4559-A818-DC231DAC1BDDQ80826552-42D529C8-04E1-4600-A794-965364BFC348Q81546511-725912C1-1E1A-418F-9616-2D39193C0627Q83334564-7D42C0A4-B903-40AC-8A67-0307830F4BD1
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Taka-aki Koshimizu
@ast
Taka-aki Koshimizu
@en
Taka-aki Koshimizu
@es
Taka-aki Koshimizu
@nl
Taka-aki Koshimizu
@sl
type
label
Taka-aki Koshimizu
@ast
Taka-aki Koshimizu
@en
Taka-aki Koshimizu
@es
Taka-aki Koshimizu
@nl
Taka-aki Koshimizu
@sl
prefLabel
Taka-aki Koshimizu
@ast
Taka-aki Koshimizu
@en
Taka-aki Koshimizu
@es
Taka-aki Koshimizu
@nl
Taka-aki Koshimizu
@sl
P106
P1153
26643110900
P2798
P31
P496
0000-0001-5292-7535